WHIPPANY, N.J., Aug. 14, 2015 /PRNewswire/ -- Bayer HealthCare will host an event for members of the bleeding disorders community, patients and their families during the National Hemophilia Foundation's (NHF) Annual Meeting taking place August 13-15 in Dallas, Texas. The dinner event will feature a keynote address from Dr. Mae Jemison, the first African-American woman astronaut, who will share her love of exploration, meeting challenges and growing up.
Also a physician, engineer and accomplished children's author, Dr. Jemison is Bayer's long-time ambassador for its award-winning "Making Science Make Sense" initiative, which advances science literacy across the United States through hands-on learning, public education, and employee volunteerism. Dr. Jemison's talk will highlight the importance of STEM (science, technology, engineering and math) education, not just for students pursuing STEM careers but for all of us in our everyday lives.
"I believe that all children are innately interested in science," said Dr. Jemison. "Frequently young people with chronic illnesses are even more likely to be engaged in and knowledgeable about science, as they gain an early command of concepts about their body and the environment in order to understand their disease and manage their health."
"Bayer has a long, proud history of working with the bleeding disorders community, and our STEM education initiatives have often aligned closely with issues that are important to patients and their families," said Dario Mirski, MD, Vice President U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals. "We must invest in our young people so they can be prepared for success as potential future innovators."
About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.
Forward Looking Statement
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer Web site at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Bayer® and the Bayer Cross® are registered trademarks of Bayer.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/national-hemophilia-foundations-nhf-67th-annual-meeting-astronaut-dr-mae-jemison-and-bayer-bring-science-education-message-to-hemophilia-patients-at-nhf-event-300128749.html
SOURCE Bayer HealthCare Pharmaceuticals Inc.